Search for Clinical Trial Results

Leukemia, Prolymphocytic, T-Cell - 15 Studies Found
Status | Study |
Completed |
Study Name: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) Condition: T-cell-prolymphocytic Leukemia Date: 2010-08-20 Interventions:
|
Withdrawn |
Study Name: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia Condition:
Date: 2010-07-12 Interventions: Drug: Velcade IV Other Name: Bortezomib |
Completed |
Study Name: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) Condition:
|
Completed |
Study Name: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condition: Prolymphocytic Leukemia Date: 2006-01-16 Interventions:
|
Recruiting |
Study Name: Registry of the German CLL Study Group Condition:
|
Recruiting |
Study Name: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant Condition:
|
Active, not recruiting |
Study Name: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma Condition:
|
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Condition:
|
Recruiting |
Study Name: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma Condition:
|